Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > VM research paper. Very thorough

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Feb 13, 2021 5:01pm

147 Views

Post# 32562869

RE:RE:RE:RE:VM research paper. Very thorough

Assume Canada is 1/10 the size.....

"The contrast media agent market in the U.S. is estimated to have been US$2.1 billion in 2017, with over 60% of the market accounted by iodine, and under 5% by barium based agents."

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project